Lower sars-cov-2 seroprevalence among cancer patients in sub-saharan africa

HIGHLIGHTS

• who: For Yue Tso et al. from the Department of Interdisciplinary Oncology, and the Stanley S Scott Cancer Center, Louisiana State University School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA have published the paper: Lower SARS-CoV-2 Seroprevalence among Cancer Patients in Sub-Saharan Africa, in the Journal: (JOURNAL)
• what: The study is unique as the authors focused on the SSA cancer population, which is consider at high-risk of developing severe COVID-19. The authors showed that this partial protection may be extended to cancer patients in SSA during the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.